Table 1.
In vivo Studies | |||||||
Disease | Animal | DM | Model | Treatment | Results | Effect | PMID |
Diabetic Nephropathy | Rat | T1D | STZ |
Hesperidin 100 mg/kg/day 2 weeks |
↓FGF-23; ↑α-Klotho | Anti-toxic in liver/kidney | 30551370 |
Rat | T1D | Alloxan |
Ramipril 5 mg/kg + Rutin 50 mg/kg/day 6 weeks |
Prevented podocyte injury, ↓TGF-β ↓ GRP78 and CHOP (ER stress markers) |
Anti-oxidant and anti-fibrotic | 30372836 | |
Rat | T1D | STZ |
Resveratrol 5 mg/kg/day 45/90 days |
↓Renal hypertrophy and structural changes. ↓AGEs accumulation; ↓oxidative stress | Renoprotective, anti-fibrotic and anti-oxidant | 29229234 | |
Rat | T1D | STZ |
Naringin 20–80 mg/kg/day 12 weeks |
↓ROS: ↑SOD and ↓NOX4 | Renoprotective and anti-oxidant | 28395989 | |
Rat | T2D | HFD/STZ |
Pyrrosiae folium 50–200 mg/kg/day 12 weeks |
↓ renal IL-6, TNF-α and IL-1β | Renoprotective and anti-inflammatory | 29945390 | |
Rat | T2D | HFD/STZ |
Formononetin 10–40 mg/kg/day. 16 weeks |
↑ creatinine clearance; ↑SIRT1; ↑SOD; ↑catalase | Renoprotective, anti-diabetic and anti-oxidant | 30641085 | |
Mouse | T1D | STZ |
Diosmetin 25–100 mg/kg/day 8 weeks |
Reduced serum FBG, BUN and creatinine and albuminuria.↓ Akt and NF-κB expression. ↑ iNOS | Renoprotective, anti-diabetic, anti-inflammatory and anti-oxidant | 30278036 | |
Mouse | T2D | db/db mouse |
Chrysin 10 mg/kg/day 10 weeks |
↓ Collagen fiber accumulation ↓ AGEs accumulation |
Anti-fibrotic | 29987200 | |
Diabetic Retinopathy | Rat | T1D | STZ |
Catechin 50–200 mg/kg/day 8 weeks |
Modulation NF-κB pathway ↓ IL-1β, IL-6, and TNF-α |
Anti-inflammatory | 30373863 |
Rat | T1D | STZ |
Biochanin A 10–15 mg/kg/day. 6 weeks |
↓ TNFα, IL-1β and VEGF | Anti-inflammatory and anti-angiogenic |
30054234 | |
Rat | T1D | STZ |
Trans-Resveratrol 5 mg/kg/day. 2–4 weeks |
↑ Cyp26b1 and Cyp3a9 transcription levels | Anti-oxidant | 30030988 | |
Rat | T1D | STZ |
Morus alba extract 100 mg/kg/day 16 weeks |
↓ Caspase-3, Bax and ↑ Bcl2; ↓TNF-α and IL-1β; ↑CAT, SOD and GPx. ↓VEGF | Anti-apoptotic, anti-oxidant, anti-inflammatory and anti-angiogenic | 27059477 | |
Rat | T1D | STZ |
Naringenin 50 mg/kg/day 5 weeks |
↑GSH; ↓Caspase-3, Bax and ↑ Bcl2; ↓pro-BDNF and ↑BDNF |
Neuroprotective, anti-oxidant and anti-apoptotic | 29064407 | |
Mouse | T1D | STZ |
Galangin 10 mg/kg/day 30 days |
↑Occludin and claudin1; ↓Iba-1 ↓ TNFα, IL-1β and IL-6 ↓p65, IκB and IKK phosphorylation |
Neuroprotective and anti-inflammatory | 30597356 | |
Mouse | T2D | db/db mouse |
Chrysin 10 mg/kg/day 10 weeks |
Increasing retinoid binding proteins (RPE65, LRAT, RDH5, and rhodopsin) | Anti-oxidant | 30096827 | |
Diabetic Neuropathy | Rat | T1D | STZ |
Catechin 25/50 mg/kg/day 4 weeks |
↑SOD and CAT ↓MDA and lymphocyte infiltration |
Neuroprotective and antioxidant | 30372853 |
Rat | T1D | STZ |
Deguelin 4–8 mg/kg/day 2 weeks |
↑Nrf2; ↓ caspase-3 in neurons ↑ (Na+-K+) ATPase activity |
Neuroprotective, anti-oxidant and anti-inflammatory | 30045011 | |
Rat | T1D | STZ |
Resveratrol 10 mg/kg/day 120 days |
↑ SOD and GSH; ↓ nitrosative stress and MPO |
Anti-oxidant and anti-inflammatory effect | 29906751 | |
Rat | T1D | STZ |
Phloretin 25–50 mg/kg/day 4 weeks |
↑ SOD and GSH ↓ IL-6 and TNF-α; ↓ MDA |
Neuroprotective, anti-oxidant and anti-inflammatory | 29635891 | |
Cardiovascular complications | Rat | T2D | HGI |
Rutin 25–50 mg/kg/day 12 weeks |
↓ inflammasome pathway in aortic tissue; ↓ROS generation | Anti-inflammatory and anti-oxidant | 27936392 |
Rat | T2D | HFD/STZ |
Resveratrol 10 mg/kg/day 8 weeks |
↓ TLR4/MyD88/NF-κB signaling pathway. | Cardioprotective and anti-inflammatory | 30658350 | |
Rat | T1D | STZ |
Apigenin 100 mg/kg/day 7 months |
↓ cardiomyocyte enlargement; ↑SOD and GPx ↓ NF-κB/p65 signaling pathway activation ↓ Col-I, Col-III, CTGF, TGFβ |
Cardioprotective, anti-oxidant, anti-inflammatory and anti-fibrotic | 28176247 | |
Rat | T1D | STZ + IRIA |
Resveratrol 5 mg/kg/day + Glibenclamide 5 mg/kg/day 6 weeks |
↑ Kir6.2 expression (subunit of KATP channel) | Anti-arrhythmic | 28176247 | |
Rat | T1D | STZ |
Heracleum Persicum 100 mg/kg/day; 8 weeks |
↓MDA; ↑GSH, CAT and SOD | Anti-oxidant | 29726706 | |
Rat | T1D | STZ |
Isoquecertin 40 mg/kg/day 45 days |
↓ TG, PPL and FFA | Anti-hyperlipidemic | 30817903 | |
Rat | T1D | STZ |
Galangin 40 mg/kg 45 days |
↓ TG, PPL, total cholesterol and FFA | Anti-hyperlipidemic | 29952676 | |
Mouse | T2D | db/db mouse |
Scutellarin 25–100 mg/kg 8 weeks |
↑ high-density lipoprotein cholesterol ↓ TG and cholesterol |
Anti-hyperlipidemic | 30881587 | |
Mouse | T2D | HFI |
Liquiritigenin 4–16 mg/kg/day |
↓NF-κB signaling pathway ↓α-SMA, Col-I, Col-II, TGF-β1 |
Anti- inflammatory and anti-fibrotic | 28039849 | |
Mouse | T2D | HFI |
Liquiritin 10/20 mg/kg/day |
↓α-SMA, Col I and Col II | Anti-fibrotic | 27810791 | |
In vitro Studies | |||||||
Disease | Cell type | Stimulus | Treatment | Results | Effect | PMID | |
Diabetic Nephropathy | Human embryonic kidney cells |
HG |
Combretum micranthum 10–25 µg/mL |
Hydrogen peroxide and nitric oxide scavenging activity | Anti-oxidant | 30976670 | |
Rat mesangial cells | HG | Marein 100–400 µM | Regulating AMPK, TGF-β1/Smads pathway ↓ NF-κB signaling pathway |
Anti-inflammatory and anti-fibrotic | 30630477 | ||
Rat/human renal tubular epithelial cells |
HG | Kaempferol 5–50 μM | ↓ RhoA/Rho Kinase signaling | Anti-inflammatory, anti-oxidant and anti-fibrotic | 30551415 | ||
Mesangial cells | HG |
Corn silkextract 200 µg/mL |
↓ α-glucosidase and α-amylase, IL-6, AGEs, Col IV and fibronectin |
Anti-inflammatory, anti-oxidant and anti-fibrotic | 30530231 | ||
Rat mesangial cells | AGEs | Kaempferitrin 10–35 µM | ↑SOD activity ↓MDA, Col IV and TGF-β1 |
Anti-oxidant and anti-fibrotic | 30373106 | ||
Rat mesangial cells | HG | Liquiritigenin 20–40 µM | ↓ NOX4 and ↑SOD Decrease collagen IV fibronectin, Il-6 and IL-1β |
Anti-oxidant, anti-inflammatory and anti-fibrotic | 30119269 | ||
Human proximal tubular epithelial cells |
HG | Astilbin 10–20 µM | Modulating PI3K/Akt pathway | Anti-proliferative | 30119185 | ||
Mouse podocyte cell line | HG | Genistein 20 µM | Inactivating mTOR signaling | Autophagia | 29999001 | ||
Human mesangial cells | HG | Chrysin 1–20 µM | ↓ Collagens, α-SMA, fibroblast-specific protein-1, MMPs | Anti-fibrotic | 29987200 | ||
Rat mesangial cells | HG | Naringin 5–80 μmol/L | Modulating NLRP3 signaling pathway ↓IL-1β, IL-18 and caspase-1 |
Anti-inflammatory and anti-apoptotic | 29929501 | ||
Rat mesangial cells | AGEs | Kaempferitrin 10–35 μM | ↓MDA levels; ↑SOD and ROS generation. ↓ Collagen IV and TGF-β1 | Anti-oxidant and anti-fibrotic | 30373106 | ||
Human mesangial cells | AGEs | Chrysin 1–20 µM | ↓ Collagens, α-SMA, fibroblast-specific protein-1, MMPs | Anti-fibrotic | 29987200 | ||
Diabetic Retinopathy | Human retinal pigment epithelial cell line |
Glucose oxidase | Myricetin 40 μg/mL | Activation of Nrf2 ↑ SOD ↓ NOS2 |
Anti-oxidant | 30820141 | |
Human retinal pigment epithelial/endothelial cells | HG | Baicalin 2.5–100 μM | Inhibition of NF-κB and p38 MAPK pathways | Anti-apoptotic and anti-inflammatory | 30625293 | ||
Human retinal pigment epithelial cell line |
H2O2 | Kaempferol 20–100 nM | Modulation Bax/Bcl-2/caspase-3 pathway; ↑ SOD and ↓VEGF | Anti-apoptotic, anti-oxidant, and anti-angiogenic | 30584457 | ||
Human retinal pigment epithelium cells |
HG | Chrysin 1–20 µM | ↓VEGF and PDGF, AGEs and ER stress |
Anti-angiogenic | 30096827 | ||
Human retinal capillary endothelial cells | HG |
Blueberry Anthocyanin 10 μg/mL |
↑CAT, SOD, ↓ Nox4 and eNOS levels ↓ICAM-1 and NF-κB; ↓VEGF |
Anti-oxidant, anti-inflammatory and anti-angiogenic | 29682153 | ||
Rat retinal ganglial cells | HG |
Eriodictyol 5–20 μM |
↓ROS and ↑ SOD, GPx, catalase ↓ TNFα, IL-8 |
Anti-oxidant and anti-inflammatory | 30317656 | ||
Mice microglia retinal cells | HG |
Galangin 20/50 µM |
↓IL-1β, TNFα;↓ NF-κB activation | Anti-inflammatory | 30597356 | ||
Diabetic Neuropathy | Rat dorsal root ganglion neurons |
HG |
Quercetin 10 mmol/L + other flavonoids |
↑ Nrf-2/HO-1 pathway; scavenging ROS ↓NF-κB activation |
Anti-oxidant and anti-inflammatory | 28861887 | |
Schwann cells | HG | Puerarin 10 µmol/L | ↓Caspase-3; ↓ROS production and mitochondria depolarization | Anti-apoptotic and anti-oxidant | 28181078 | ||
Rat dorsal root ganglion neurons |
HG | Quercetin 2.5–10 mmol/L | ↑ Nrf-2/HO-1; ↓ NF-κB inhibition | Anti-oxidant and anti-inflammatory | 23770986 | ||
Cardiovascular complications | Human aortic endothelial cells |
Palmitic acid |
Blueberry Anthocyanins 12–16 nmol |
↓Nox-mediated ROS production | Anti-oxidant | 29024402 | |
Human umbilical vein endothelial cells |
HG | Rutin 30–100 µM | ↓Nox2 and Nox4 | Anti-oxidant | 27936392 | ||
Human aortic endothelial cells |
Palmitic acid | Resveratrol 50–100 µM | ↓ ROS production via AMPK-mTOR pathway | Autophagia and anti-oxidant | 30421395 |